Eloctate 71104-0804
Generic: Antihemophilic Factor (recombinant), Fc Fusion Protein
Product NDC
71104-0804- Manufacturer
- Bioverativ Therapeutics Inc.
- Dosage Form
- Kit
- Route
- Intravenous
- Product Type
- Plasma Derivative
- Marketing Start
- September 6, 2017
- Listing Expires
- December 31, 2026
- Application
- BLA125487
Packaging Options(1)
1 KIT in 1 KIT (71104-804-01) * 3 mL in 1 VIAL (71104-486-08) * 3 mL in 1 SYRINGE (71104-035-01)
External Resources